The Board advises the Trust regarding its scientific direction and focus. It currently has three members:
Professor Eamonn Maher MD FRCP FMedSci, Professor of Medical Genetics at Birmingham University, UK. Professor Maher’s work focuses on human genetic disorders. Current research interests include inherited and non-inherited kidney cancers, such as VHL and BHD syndrome.
Dr Laura Schmidt PhD, Principal Scientist at the National Cancer Institute, NIH, USA. Dr Schmidt’s research focuses on identifiying new genes involved in familial renal cancer. Dr Schmidt was part of the teams that cloned the VHL tumor suppressor gene, and that identified mutations in Folliculin, the gene mutated in BHD syndrome.
prof. dr. Maurice van Steensel MD PhD, Professor of Genodermatology and Vice Chair of Dermatology at Maastricht University Center for Molecular Dermatology, University Hospital Maastricht, The Netherlands. prof. dr. van Steensel works on congenital dermatological disorders. He has described several novel mutations in Folliculin.
Report of the Board’s third meeting, held on 16th of November 2009, here.
Report of the Board’s second meeting, held on 3rd of September 2008, here.
Report of the Board’s first meeting, held on 8th of May 2008, here.
